Last reviewed · How we verify

NCT05884788: RECIFE

Study of the Life Stories of Patients Making a Request for Euthanasia, in the Context of Advanced Cancer.

Completed Last updated 16 April 2025
What this trial tests

trial testing free interview, and questionnaires in a second time in Advanced Cancer in 7 participants. Completed in 31 July 2024.

Timeline
1 June 2023
Primary endpoint
31 July 2024
31 July 2024

Quick facts

Lead sponsorCentre Leon Berard
StatusCompleted
Study typeOBSERVATIONAL
Enrollment7
Start date1 June 2023
Primary completion31 July 2024
Estimated completion31 July 2024
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Leon Berard — full company profile →

Who can join

18 and older, any sex, with Advanced Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study wishes to focus on the life course of patients, beyond the moments of suffering experienced at the time of the request for euthanasia. It is based on the perspective that the patient's account of his or her life course can be a source of information for better understanding and accompanying patients requesting euthanasia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Advanced Cancer

Currently open trials in the same condition.

Other Centre Leon Berard trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05884788.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing